Page last updated: 2024-12-08

pinoresinol diglucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pinoresinol diglucoside: major antihypertensive principle of Tu-Chung (Eucummia ulmoides, Oliver); structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID174003
CHEMBL ID450911
MeSH IDM0060792

Synonyms (19)

Synonym
pinoresinol diglucoside
CHEMBL450911
(2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
63902-38-5
beta-d-glucopyranoside, (tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2-methoxy-4,1-phenylene) bis-, (1s-(1alpha,3aalpha,4alpha,6aalpha))-
S9215
AKOS025311591
ZJSJQWDXAYNLNS-FUPWJLLWSA-N
pinoresinol diglucopyranoside
Q-100734
pinoresinol-diglucoside
AC-31295
HY-N0657
DTXSID50213522
pinoresinol diglucoside, >=98% (hplc)
(2r,2'r,3s,3's,4s,4's,5r,5'r,6s,6's)-6,6'-((((1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(2-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol)
mfcd06656077
CCG-270370
pinoresinoldiglucoside

Research Excerpts

Effects

ExcerptReferenceRelevance
"Pinoresinol diglucoside (PDG) has antioxidation and anti-inflammation activities."( Pinoresinol diglucoside alleviates ischemia/reperfusion-induced brain injury by modulating neuroinflammation and oxidative stress.
Feng, G; Lei, Y; Yao, X; Yi, J; Zhang, Y, 2021
)
2.79

Pharmacokinetics

ExcerptReferenceRelevance
"The results showed that following the use of the two medicinal plants, for AU and GP, the values of Cmax markedly increased, and the values of cmax markedly decreased."( LC/MS/MS determination and pharmacokinetic studies of six compounds in rat plasma following oral administration of the single and combined extracts of Eucommia ulmoides and Dipsacus asperoides.
Gao, XM; Huang, YX; Huo, Y; Liu, EW; Olaleye, O; Wang, L; Wang, Q; Wang, T, 2014
)
0.4

Compound-Compound Interactions

ExcerptReferenceRelevance
"To develop a quantitative models for simultaneous determination of pinoresinol diglucoside (PDG) and geniposidic acid (GPA) in Eucommia ulmoides with near-infrared (NIR) spectroscopy combined with chemometrics."( [Rapid Determination of Pinoresinol Diglucoside and Geniposidic Acid in Eucommia ulmoides with Near Infrared Spectroscopy Combined with Chemometrics Methods].
Li, FF; Liu, R; Liu, S; Peng, YZ; Xu, XB; Zi, W, 2016
)
0.98

Bioavailability

ExcerptReferenceRelevance
" These results could be used to help improve the bioavailability of SL and obtaining high quality sesame byproducts."( Effects of thermal preparation and in vitro digestion on lignan profiles and antioxidant activity in defatted-sesame meal.
Chen, J; Chen, Y; Lin, H; Lin, M; Lin, P, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID336466Displacement of [3H]flunitrazepam from GABAA receptor in rat brain cortical membrane at 10 uM2002Journal of natural products, Oct, Volume: 65, Issue:10
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's3 (10.00)18.2507
2000's4 (13.33)29.6817
2010's16 (53.33)24.3611
2020's5 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.90 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]